"US Reliance on China for Pharmaceuticals Rises, Sparking National Security Concerns. As the US continues to face a critical shortage of essential medications, a growing reliance on China for pharmaceuticals is raising alarms about the potential for the Chinese Communist Party to exert control over the global supply chain. With China's dominance in the production of active pharmaceutical ingredients (APIs) and finished goods, the US is increasingly vulnerable to disruptions in supply, which could have devastating consequences for public health. Experts warn that the country's dependence on China for pharmaceuticals poses a significant national security risk, highlighting the need for bold leadership and policies that prioritize domestic innovation and production to safeguard the nation's healthcare."
The United States is increasingly reliant on China for pharmaceuticals, with the potential for the Chinese Communist Party to gain control of the global supply chain, posing a national security risk that must be addressed through leadership and policies that foster pharmaceutical innovation at home.
